Our study shows that SOX9 was upregulated in ESCC and was correlated with the malignant features of ESCC, such as clinical stage, tumor-nodes-metastasis (TNM) classification, tumor differentiation, tumor size, and survival, indicating that SOX9 could serve as a useful diagnostic and prognostic biomarker. This evidence concerns the gene SOX9 and neoplasm.